Share
   
Title
Code
Session Type
Venue
Date Time
Co-Chairs:
Organizer:

Increased access to viral load testing is one of the conditions needed to reach the 3rd "90" of the global goal set by UNAIDS by 2020, which means 90% of patients receiving ART are virally suppressed. However, access and implementation of viral load testing face a number of obstacles in resource-limited settings. In light of the OPP-ERA project, funded by Unitaid and ANRS and implemented in Western and Central Africa, this symposium will explore and discuss the existing solutions and the remaining technical, economical and political challenges.

18:30
TUSA1101
Welcome by the chair
Robert Matiru, UNITAID, Switzerland
18:35
TUSA1102
The global situation of viral load testing for treatment monitoring
Dr Lara Vojnov, Diagnostic Advisor, WHO, Switzerland
Slides
18:42
TUSA1103
Which solutions for which context ? Introduction of the 1st round table
Pr Coumba Touré Kane, Virologist, University Hospital Dalal Jamm, Cheikh Anta Diop University, Senegal
18:47
TUSA1104
HIV Viral Load technologies: Which solution for which context?
Pr Christine Rouzioux, Virologist, Paris Descartes University, Necker University Hospital, France
Slides
18:54
TUSA1106
HIV VL platforms and patient needs: Where the market is going?
Pr Benjamin Coriat, Economist, Paris XIII University, France
Slides
19:03
TUSA1107
Discussion
Dr Annette Reinisch, Senior Disease Advisor HIV, Global Fund, Switzerland
Emmanuel Fajardo, Médecins Sans Frontières (MSF) Access Campaign, Switzerland
Dr Avelin Aghokeng, Virologist, Institut de Recherche pour le Développement, Cameroon
19:26
Video
19:31
TUSA1108
What are the minimum requirements for an enabling environment to implement and scale up HIV viral load? Introduction of the 2nd round-table
Pr François Dabis, Director, ANRS, France
19:36
TUSA1110
Enabling the environment: a key to sucessfully achieve ‘the third 90’
Dr Louis Pizarro, CEO of Solthis, France
19:43
TUSA1105
Programmatic and technical benefits and challenges of laboratory networks and technologies – Uganda Experience
Mr Charles Kiyaga, LabCoP, Program Manager, ASLM, Uganda
Slides
19:50
TUSA1111
Discussion
Ms Jeanne Gapiya, President, ANSS, Burundi
Pr Serge Eholié, RESAPSI, Cote D'Ivoire
Pr Mohamed Cissé, Donka University Hospital, Guinea
20:15
TUSA1112
Conclusion
Pr François Dabis, Director, ANRS, France